Ravi Medikonda

840 total citations
33 papers, 534 citations indexed

About

Ravi Medikonda is a scholar working on Oncology, Genetics and Surgery. According to data from OpenAlex, Ravi Medikonda has authored 33 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Genetics and 6 papers in Surgery. Recurrent topics in Ravi Medikonda's work include Glioma Diagnosis and Treatment (12 papers), Cancer Immunotherapy and Biomarkers (6 papers) and CAR-T cell therapy research (5 papers). Ravi Medikonda is often cited by papers focused on Glioma Diagnosis and Treatment (12 papers), Cancer Immunotherapy and Biomarkers (6 papers) and CAR-T cell therapy research (5 papers). Ravi Medikonda collaborates with scholars based in United States, United Kingdom and South Korea. Ravi Medikonda's co-authors include Michael Lim, Maryam Rahman, Gavin P. Dunn, Peter E. Fecci, Ayush Pant, John Choi, Luqing Tong, Tianna Zhao, Xuya Wang and Jun Dong and has published in prestigious journals such as Cancer, Journal of neurosurgery and Neurosurgery.

In The Last Decade

Ravi Medikonda

30 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ravi Medikonda United States 10 186 170 170 138 74 33 534
Hidenori Kasahara Japan 9 137 0.7× 60 0.4× 81 0.5× 203 1.5× 44 0.6× 21 476
Yufang Zhu China 13 89 0.5× 117 0.7× 70 0.4× 162 1.2× 73 1.0× 41 518
Fengping Wu China 7 52 0.3× 86 0.5× 124 0.7× 149 1.1× 40 0.5× 10 480
Xinyu Ti China 11 138 0.7× 82 0.5× 94 0.6× 303 2.2× 122 1.6× 28 629
Marion Lebois Australia 11 95 0.5× 113 0.7× 224 1.3× 376 2.7× 60 0.8× 15 707
Shaoda Ren China 10 95 0.5× 135 0.8× 87 0.5× 127 0.9× 46 0.6× 16 385
Lucy A. Coupland Australia 15 199 1.1× 39 0.2× 93 0.5× 221 1.6× 77 1.0× 39 583
Karim Harhouri France 14 115 0.6× 52 0.3× 122 0.7× 561 4.1× 46 0.6× 19 778
Chiyo Doi United States 11 166 0.9× 262 1.5× 37 0.2× 212 1.5× 44 0.6× 11 522
Racheal G. Akwii United States 7 114 0.6× 36 0.2× 83 0.5× 284 2.1× 54 0.7× 12 592

Countries citing papers authored by Ravi Medikonda

Since Specialization
Citations

This map shows the geographic impact of Ravi Medikonda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Medikonda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Medikonda more than expected).

Fields of papers citing papers by Ravi Medikonda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Medikonda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Medikonda. The network helps show where Ravi Medikonda may publish in the future.

Co-authorship network of co-authors of Ravi Medikonda

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Medikonda. A scholar is included among the top collaborators of Ravi Medikonda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Medikonda. Ravi Medikonda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Medikonda, Ravi, et al.. (2026). Endogenous immune recruitment in glioblastoma CAR T therapy: cytokine, myeloid, and chemokine circuitry. Journal of Neuro-Oncology. 177(1).
3.
Medikonda, Ravi, et al.. (2025). The Metabolic Orchestration of Immune Evasion in Glioblastoma: From Molecular Perspectives to Therapeutic Vulnerabilities. Cancers. 17(11). 1881–1881. 13 indexed citations
4.
Medikonda, Ravi, et al.. (2025). Top advances of the year: The status of chimeric antigen receptor T cells in neuro‐oncology. Cancer. 131(12). e35935–e35935. 6 indexed citations
5.
6.
Medikonda, Ravi, et al.. (2025). Emerging trends in cell-based therapies: contemporary advances and ethical considerations in translational neurosurgical oncology. Journal of Neuro-Oncology. 175(1). 1–20. 8 indexed citations
7.
Cho, Kwang Bog, Jaejoon Lim, Lily H. Kim, et al.. (2025). The immunological landscape of traumatic brain injury: insights from pathophysiology to experimental models. Frontiers in Neurology. 16. 1668480–1668480. 1 indexed citations
8.
Choi, John, et al.. (2025). TMIC-43. Tumor-Associated Neutrophils: A Double-Edged Sword in Glioblastoma Progression. Neuro-Oncology. 27(Supplement_5). v453–v453. 2 indexed citations
9.
10.
Medikonda, Ravi, Ayush Pant, & Michael Lim. (2023). Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors. Advances in experimental medicine and biology. 1394. 73–84. 6 indexed citations
11.
Xu, Risheng, Giho Park, Ravi Medikonda, et al.. (2022). Safety and Cost Savings Associated with Reduced Inpatient Hospitalization for Microvascular Decompression. World Neurosurgery. 166. e504–e510. 1 indexed citations
12.
Lubelski, Daniel, James Feghali, Jeff Ehresman, et al.. (2021). Web-Based Calculator Predicts Surgical-Site Infection After Thoracolumbar Spine Surgery. World Neurosurgery. 151. e571–e578. 9 indexed citations
13.
Pennington, Zach, Jeff Ehresman, Camilo A. Molina, et al.. (2020). A novel predictive model of intraoperative blood loss in patients undergoing elective lumbar surgery for degenerative pathologies. The Spine Journal. 20(12). 1976–1985. 5 indexed citations
14.
Tong, Luqing, Jiabo Li, Xuya Wang, et al.. (2020). ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma. Theranostics. 10(13). 5943–5956. 112 indexed citations
15.
Pant, Ayush, Ravi Medikonda, & Michael Lim. (2020). Alternative Checkpoints as Targets for Immunotherapy. Current Oncology Reports. 22(12). 126–126. 14 indexed citations
16.
Medikonda, Ravi, Gavin P. Dunn, Maryam Rahman, Peter E. Fecci, & Michael Lim. (2020). A review of glioblastoma immunotherapy. Journal of Neuro-Oncology. 151(1). 41–53. 193 indexed citations
17.
Pant, Ayush, et al.. (2020). IMMU-13. EFFICACY OF CXCR6 BLOCKADE AS A POTENTIATOR OF ANTI-PD-1 THERAPY FOR THE TREATMENT OF GLIOBLASTOMA. Neuro-Oncology. 22(Supplement_2). ii107–ii107. 1 indexed citations
18.
Ehresman, Jeff, Zach Pennington, Andrew Schilling, et al.. (2020). Cost-benefit analysis of tranexamic acid and blood transfusion in elective lumbar spine surgery for degenerative pathologies. Journal of Neurosurgery Spine. 33(2). 177–185. 32 indexed citations
19.
Medikonda, Ravi, Siddhartha Srivastava, Christina Jackson, et al.. (2020). NCOG-32. THE SAFETY AND EFFICACY OF DEXAMETHASONE IN THE MANAGEMENT OF GLIOMA PATIENTS. Neuro-Oncology. 22(Supplement_2). ii136–ii136. 1 indexed citations
20.
Medikonda, Ravi, Chin Siang Ong, Jamie McElrath Schwartz, et al.. (2019). Trends and Updates on Cardiopulmonary Bypass Setup in Pediatric Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia. 33(10). 2804–2813. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hidenori Kasahara Breakdown of academic impact, for papers by Yufang Zhu Breakdown of academic impact, for papers by Fengping Wu Breakdown of academic impact, for papers by Xinyu Ti Breakdown of academic impact, for papers by Marion Lebois Breakdown of academic impact, for papers by Shaoda Ren Breakdown of academic impact, for papers by Lucy A. Coupland Breakdown of academic impact, for papers by Karim Harhouri Breakdown of academic impact, for papers by Chiyo Doi Breakdown of academic impact, for papers by Racheal G. Akwii
Rankless by CCL
2026